Seaport Therapeutics Overview
- Year Founded
-
2020
- Status
-
Public
- Employees
-
58
- Stock Symbol
-
SPTX
- Share Price
-
$18.05
- (As of Friday Closing)
Seaport Therapeutics General Information
Description
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
Contact Information
Website
www.seaporttx.comCorporate Office
- 101 Seaport Boulevard, Floor 12
- Seaport Boston
- Boston, MA 02210
- United States
Corporate Office
- 101 Seaport Boulevard, Floor 12
- Seaport Boston
- Boston, MA 02210
- United States
Seaport Therapeutics Timeline
Seaport Therapeutics Stock Performance
As of 20-Nov-2026, Seaport Therapeutics’s stock price is $18.05. Its current market cap is $966M with 53.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.05 | $18.32 | $14.85 - $28.38 | $966M | 53.5M | 257K | -$4.35 |
Seaport Therapeutics Financials Summary
As of 30-Sep-2026, Seaport Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| EV | 811,418 | ||
| Revenue | 0 | 0 | 0 |
| EBITDA | (147,507) | (84,106) | (52,202) |
| Net Income | (138,537) | (74,881) | (46,879) |
| Total Assets | 417,624 | 249,009 | 315,777 |
| Total Debt | 4,686 | 5,081 | 5,006 |
Seaport Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Seaport Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Seaport Therapeutics Comparisons
Industry
Financing
Details
Seaport Therapeutics Competitors (3)
One of Seaport Therapeutics’s 3 competitors is Eumentis Therapeutics, a Venture Capital-Backed company based in Solana Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eumentis Therapeutics | Venture Capital-Backed | Solana Beach, CA | ||||
| Marinus Pharmaceuticals | Private Equity-Backed | Radnor, PA | ||||
| Arialys Therapeutics | Venture Capital-Backed | La Jolla, CA |
Seaport Therapeutics Patents
Seaport Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026180971-A1 | Cbd prodrug formulation and methods of treatment | Pending | 25-Feb-2025 | ||
| AU-2024404697-A1 | Lipid prodrugs of agomelatine | Pending | 19-Dec-2023 | ||
| EP-4827814-A1 | Lipid prodrugs of agomelatine | Pending | 19-Dec-2023 | ||
| WO-2025137181-A1 | Lipid prodrugs of agomelatine | Inactive | 19-Dec-2023 | ||
| AU-2024382402-A1 | Lipid prodrugs of allopregnanolone and uses thereof | Pending | 13-Nov-2023 | A61P25/24 |
Seaport Therapeutics Signals
Seaport Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Seaport Therapeutics FAQs
-
When was Seaport Therapeutics founded?
Seaport Therapeutics was founded in 2020.
-
Where is Seaport Therapeutics headquartered?
Seaport Therapeutics is headquartered in Boston, MA.
-
What is the size of Seaport Therapeutics?
Seaport Therapeutics has 58 total employees.
-
What industry is Seaport Therapeutics in?
Seaport Therapeutics’s primary industry is Drug Discovery.
-
Is Seaport Therapeutics a private or public company?
Seaport Therapeutics is a Public company.
-
What is Seaport Therapeutics’s stock symbol?
The ticker symbol for Seaport Therapeutics is SPTX.
-
What is the current stock price of Seaport Therapeutics?
As of 20-Nov-2026 the stock price of Seaport Therapeutics is $18.05.
-
What is the current market cap of Seaport Therapeutics?
The current market capitalization of Seaport Therapeutics is $966M.
-
Who are Seaport Therapeutics’s competitors?
Eumentis Therapeutics, Marinus Pharmaceuticals, and Arialys Therapeutics are competitors of Seaport Therapeutics.
-
What is Seaport Therapeutics’s annual earnings per share (EPS)?
Seaport Therapeutics’s EPS for 12 months was -$4.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process